CELLINK Designed the Most Flexible Six-Printhead Bioprinting Platform on the Market

CELLINK Designed the Most Flexible Six-Printhead Bioprinting Platform on the Market

September 10, 2019

CELLINK has come up with BIO X6, a six-printhead bioprinting platform that enables users to combine more materials, cells and tools than any other system on the market. It is the only bioprinter that combines six printheads with patented Clean Chamber technology and Intelligent Exchangeable Printhead Technology of CELLINK.

The mission of CELLINK is to provide innovative technologies to aid the cutting-edge research of scientist worldwide. The BIO X6 is the platform that is offering solution to the advanced tissue engineers, regenerative medicine labs and cancer biologists through bioprinting and dispensing.

Organs and tissues are comprised of many different cell types. With the BIO X6, users can combine six or more cell types to print advanced organ and tissue models.

The BIO X6 gives the user freedom to combine multiple materials in one print, and the capability to create more complex architectures.

Being anle to use different pressures, temperatures and printing methods simultaneously in six different positions in revolutionary. Users can mix the cells in each printhead with a tailored biolink, providing the cells with the biological environment they need to achieve the desired architecture,” said by Itedale Namro Redwan, Chief Scientific Officer at CELLINK.

CELLINK has developed the new technology based in the award-winning BIO X platform of CELLINK, in order to advance research and clinical applications in the bioprinting field. The system features a movable arm count, enabling multiple possibilities in one system. The control system of the technology can be through a Wi-Fi connection or also through a detachable tablet on the movable arm mount.

Source: CELLINK

 

Author : Meha Prasad

Tags :

Healthcare
x

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy and Cookie Policy. By continuing to use this site or closing this box, you consent to our use of cookies! Accept